kabutan

Delta-Fly Pharma, Inc.(4598) Summary

4598
TSE Growth
Delta-Fly Pharma, Inc.
521
JPY
+9
(+1.76%)
Dec 5, 12:45 pm JST
3.35
USD
Dec 4, 10:45 pm EST
Result
PTS
outside of trading hours
518.1
Dec 5, 12:38 pm JST
Summary Chart Historical News Financial Result
PER
PBR
17.4
Yield
ー%
Margin Trading Ratio
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
513 JPY 3.30 USD
Previous Close Dec 4
512 JPY 3.29 USD
High Dec 5, 9:11 am
538 JPY 3.46 USD
Low Dec 5, 9:00 am
512 JPY 3.30 USD
Volume
251,600
Trading Value
0.13B JPY 0.85M USD
VWAP
526.52 JPY 3.39 USD
Minimum Trading Value
52,100 JPY 335 USD
Market Cap
6.13B JPY 0.04B USD
Number of Trades
468
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
Slightly High
1-Year Average
911
1-Year High Dec 12, 2024
14,239
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 600 2,068,700 3447.83
Nov 21, 2025 0 2,140,400
Nov 14, 2025 900 2,115,000 2350.00
Nov 7, 2025 1,600 1,853,100 1158.19
Oct 31, 2025 0 1,870,400
Company Profile
Delta-Fly Pharma, Inc. is a bioventure company developing anticancer drugs. The company handles everything from research and development to manufacturing and sales.
Sector
Pharmaceuticals
Delta-Fly Pharma, Inc. is a bioventure company that consistently handles the entire process from research and development to manufacturing and sales of anticancer drugs. Using its proprietary "modular drug discovery" method, the company aims to create new anticancer drugs with an excellent balance of clinical efficacy and safety by combining existing anticancer active substances. With multiple development pipelines, the company is conducting clinical trials targeting recurrent and refractory acute myeloid leukemia, lung cancer, pancreatic cancer, and other conditions. Their business model is based on generating revenue through product sales, milestone payments, and royalty income by out-licensing sales rights to pharmaceutical companies. Focusing on licensing agreements with pharmaceutical companies, Delta-Fly Pharma has established an efficient research and development system by utilizing external resources.